title: Autologous fibroblast suspension for the treatment of refractory diabetic foot ulcer.
authors.forename: Mohammad Ali
authors.initials: MA
authors.lastname: Nilforoushzadeh
authors.forename: Fariba
authors.initials: F
authors.lastname: Jaffary
authors.forename: Mansour
authors.initials: M
authors.lastname: Siavash
authors.forename: Nazli
authors.initials: N
authors.lastname: Ansari
authors.affiliation: Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran.
authors.forename: Amir Hossein
authors.initials: AH
authors.lastname: Siadat
authors.forename: Asieh
authors.initials: A
authors.lastname: Heidari
mesh_terms: D017690:Cell Transplantation / Q000379:methods; D003646:Debridement / Q000379:methods*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D017719:Diabetic Foot / Q000175:diagnosis / Q000628:therapy*; D005347:Fibroblasts / Q000637:transplantation*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D012720:Severity of Illness Index; D014182:Transplantation, Autologous; D016896:Treatment Outcome; D014238:Trichloroacetic Acid / Q000494:pharmacology; D014945:Wound Healing / Q000502:physiology*
chemical_list: D014238:Trichloroacetic Acid